We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

New SPECT System Launched as Nuclear Cardiology Solution

By Medimaging International staff writers
Posted on 26 Sep 2017
Print article
Image: The new CardioMD IV SPECT solution (Photo courtesy of Philips Healthcare).
Image: The new CardioMD IV SPECT solution (Photo courtesy of Philips Healthcare).
A large global healthcare equipment manufacturer has highlighted a new nuclear cardiology solution that uses Single Photon Emission Computed Tomography (SPECT) technology, cardiac quantification software, and advanced reconstruction to improve the cardiac imaging workflow and diagnostic confidence.

The system was designed specifically as a cardiac SPECT solution that fits the needs of healthcare institutions, both economic, and clinical.

The novel CardioMD IV cardiac SPECT system was developed by Royal Philips (Amsterdam, the Netherlands). The system has a small footprint, and is designed to fit in an existing camera room without the need for costly room renovations. The system has a patient-friendly design, and offers improved positioning flexibility. The CardioMD IV can perform cardiac imaging much faster than previous systems.

The CardioMD IV also features Philips’ Astonish reconstruction technology that can improve workflow efficiency, while providing the same image quality. The system also works with Philips’ IntelliSpace Portal advanced visualization, and analysis platform. By using IntelliSpace the CardioMD IV SPECT reporting, quantification, and review applications become available to the whole enterprise, and can facilitate more efficient collaboration between referring physicians, and cardiologists.

Business Leader, Advanced Molecular Imaging, at Philips Healthcare, Kirill Shalyaev, PhD, said, "Our aim is to advance molecular imaging in all disease areas, and provide dependable imaging solutions to enhance diagnostic confidence and patient care at lower costs. CardioMD IV delivers the reliable performance and the low total cost of ownership that nuclear cardiology practices need to drive clinical, financial and operational efficiencies."

Print article


Copyright © 2000-2018 Globetech Media. All rights reserved.